1. Clinicopathologic and genetic characterization of angiofibroma of soft tissue: a study of 12 cases including two cases with AHRR::NCOA3 gene fusion
   Kyoko Yamashita et al, 2023, Histopathology CrossRef
2. Soft tissue angiofibroma: Clinicopathologic, immunohistochemical and molecular analysis of 14 cases
   Elise M Bekers et al, 2017, Genes, Chromosomes and Cancer CrossRef
3. Novel fusion genes in spindle cell rhabdomyosarcoma: The spectrum broadens
   Diego M. Montoya‐Cerrillo et al, 2021, Genes, Chromosomes and Cancer CrossRef
4. Current Approaches for Personalized Therapy of Soft Tissue Sarcomas
   Kirill I. Kirsanov et al, 2020, Sarcoma CrossRef
5. CYP1A1 Is a Useful Diagnostic Marker for Angiofibroma of Soft Tissue
   Kotaro Uemura et al, 2023, American Journal of Surgical Pathology CrossRef
6. Novel MEIS1-NCOA2 Gene Fusions Define a Distinct Primitive Spindle Cell Sarcoma of the Kidney
   Pedram Argani et al, 2018, American Journal of Surgical Pathology CrossRef
7. PRRX‐NCOA1/2 rearrangement characterizes a distinctive fibroblastic neoplasm
   Maribel D. Lacambra et al, 2019, Genes, Chromosomes and Cancer CrossRef
8. Angiofibroma of Soft Tissue: A Clinicopathological Study of Eight Cases With Emphasis on the Diagnostic Utility of Fluorescence In Situ Hybridization Detection for NCOA2 Rearrangement
   Canming Wang et al, 2022, Frontiers in Oncology CrossRef
9. E26 transformation-specific variant 4 as a tumor promotor in human cancers through specific molecular mechanisms
   Wenxiao Jiang et al, 2021, Molecular Therapy - Oncolytics CrossRef
10. Low-grade undifferentiated sarcoma with MEIS1::NCOA2-rearrangement primary to the lung: a case report
    Zachary Coty-Fattal et al, 2024, Diagnostic Pathology CrossRef
11. Detection of sarcoma fusions by a next-generation sequencing based–ligation-dependent multiplex RT-PCR assay
    Marie-Delphine Lanic et al, 2022, Modern Pathology CrossRef
12. Fusion Oncoproteins in Childhood Cancers: Potential Role in Targeted Therapy
    Sara D. A. Angione et al, 2021, The Journal of Pediatric Pharmacology and Therapeutics CrossRef
13. Soft tissue angiofibroma with atypical features
    Suzanna J. Logan et al, 2020, Human Pathology: Case Reports CrossRef
14. Genomic profiling identifies genes and pathways dysregulated by HEY1–NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis
    Wenqing Qi et al, 2022, The Journal of Pathology CrossRef
15. A concise review of angiofibroma of soft tissue: A rare newly described entity that can be encountered by dermatopathologists
    Andres E. Mindiola‐Romero et al, 2020, Journal of Cutaneous Pathology CrossRef
16. Expanding the Spectrum of Intraosseous Rhabdomyosarcoma
    Narasimhan P. Agaram et al, 2019, American Journal of Surgical Pathology CrossRef
17. p160 nuclear receptor coactivator family members and their role in rare fusion‑driven neoplasms (Review)
    Danilo Segovia et al, 2024, Oncology Letters CrossRef
18. Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology
    Marc El Beaino et al, 2018, Current Oncology Reports CrossRef